These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 11271220

  • 1. Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients.
    Taesch S, Niese D.
    Transpl Int; 1994; 7 Suppl 1():S263-6. PubMed ID: 11271220
    [Abstract] [Full Text] [Related]

  • 2. Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral.
    Otto MG, Mayer AD, Clavien PA, Cavallari A, Gunawardena KA, Mueller EA.
    Transplantation; 1998 Dec 27; 66(12):1632-40. PubMed ID: 9884251
    [Abstract] [Full Text] [Related]

  • 3. Safety and tolerability of CyA microemulsion formulation (Sandimmun Neoral) in stable renal transplant patients after 24 months of treatment. German Neoral Study Group.
    Offermann G, Korn A.
    Transplant Proc; 1996 Aug 27; 28(4):2204-6. PubMed ID: 8769201
    [No Abstract] [Full Text] [Related]

  • 4. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.
    Keown P, Niese D.
    Kidney Int; 1998 Sep 27; 54(3):938-44. PubMed ID: 9734620
    [Abstract] [Full Text] [Related]

  • 5. Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period.
    Wahlberg J, Wilczek HE, Fauchald P, Nordal KP, Heaf JG, Olgaard K, Hansen JM, Lokkegaard H, Mueller EA, Kovarik JM.
    Transplantation; 1995 Oct 15; 60(7):648-52. PubMed ID: 7570970
    [Abstract] [Full Text] [Related]

  • 6. Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group.
    Frei UA, Neumayer HH, Buchholz B, Niese D, Mueller EA.
    Transplantation; 1998 Jun 15; 65(11):1455-60. PubMed ID: 9645802
    [Abstract] [Full Text] [Related]

  • 7. [Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients].
    Sperschneider H, Wagner C, Korn A, Christians U.
    Med Klin (Munich); 1997 Oct 15; 92(10):589-96. PubMed ID: 9446006
    [Abstract] [Full Text] [Related]

  • 8. Neoral induction in pediatric renal transplantation.
    Bunchman TE, Parekh RS, Flynn JT, Smoyer WE, Kershaw DB, Valentini RP, Pontillo BJ, Sandvordenker J, Brown C, Sedman AB.
    Pediatr Nephrol; 1998 Jan 15; 12(1):2-5. PubMed ID: 9502556
    [Abstract] [Full Text] [Related]

  • 9. Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
    Buchholz B, Korn A.
    Transplant Proc; 1996 Aug 15; 28(4):2187-8. PubMed ID: 8769195
    [No Abstract] [Full Text] [Related]

  • 10. Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study Group.
    Yocum DE, Allard S, Cohen SB, Emery P, Flipo RM, Goobar J, Jayawardena S, Job-Deslandre C, Jubb RW, Krüger K, Lopes Vaz A, Manger B, Mur E, Nygaard H, Weiner SM, Rainer F, Sack MR, Schiff MH, Schnitzer TJ, Trigg LB, Whatmough I, Schmidt AG.
    Rheumatology (Oxford); 2000 Feb 15; 39(2):156-64. PubMed ID: 10725065
    [Abstract] [Full Text] [Related]

  • 11. Sandimmun neoral, a new oral formulation of cyclosporin A with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patients.
    Taesch S, Niese D, Mueller EA.
    Transplant Proc; 1994 Dec 15; 26(6):3147-9. PubMed ID: 7998097
    [No Abstract] [Full Text] [Related]

  • 12. Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.
    Dunn CJ, Wagstaff AJ, Perry CM, Plosker GL, Goa KL.
    Drugs; 2001 Dec 15; 61(13):1957-2016. PubMed ID: 11708766
    [Abstract] [Full Text] [Related]

  • 13. Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients.
    Tsang WK, Ho YW, Tong KL, Chan WH, Chan A.
    Transplant Proc; 1996 Jun 15; 28(3):1330-2. PubMed ID: 8658681
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of grapefruit juice on Sandimmun Neoral absorption among stable renal allograft recipients.
    Bistrup C, Nielsen FT, Jeppesen UE, Dieperink H.
    Nephrol Dial Transplant; 2001 Feb 15; 16(2):373-7. PubMed ID: 11158415
    [Abstract] [Full Text] [Related]

  • 17. Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients. The U.K. Neoral Renal Study Group.
    Pollard SG, Lear PA, Ready AR, Moore RH, Johnson RW.
    Transplantation; 1999 Nov 15; 68(9):1325-31. PubMed ID: 10573071
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).
    Noble S, Markham A.
    Drugs; 1995 Nov 15; 50(5):924-41. PubMed ID: 8586033
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.